Reduced plasma c-AMP levels in children with atopic dermatitis

Pediatric Allergy and Immunology

Volumn 9, Issue 3, 1998, Pages 130-132

  Salpietro, Damiano Carmelo ^a,d   Naccari, Francesco ^b   Polimeni, Isabella ^c   Pellegrino, Cristina ^b  

^a Department of Pediatric Therapy   (Italy)

^b Dept of Med and Vet Pharmacology ^*  (Italy)

^c UNIVERSITY OF MESSINA   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

Atopic dermatitis; c AMP; Children; Plasma levels

Indexed keywords

CYCLIC AMP; IMMUNOGLOBULIN E;

ARTICLE; ATOPIC DERMATITIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOGENESIS; INFANT; MALE; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 0031721923     PISSN: 09056157     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3038.1998.tb00358.x     Document Type: Article

References (18)

1. COOKSON W, SHARPP A, FAUX JA, HOPKIN JM. Linkage between immunoglobulin and responses underlying asthma and rhinitis and chromosome 11q. Lancet 1989: 1292-5.
2. KAY ABM, YING S, VARNEY V, et al. Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL3), IL4, IL5 and granulocyte-macrophage colony-stimulating-factor, in allergen-induced late-phase reaction in atopic subjects. Exp Med 1991: 173: 775-81.
3. RICCI M. IL4: A key cytokine in atopy. Clin Exp All 1994: 24: 801-12.
4. HANIFIN JM, CHAN SC. Monocyte dysregulation of T cells in Atopic Dermatitis. ACI News 1995: 7/2: 48-50.
5. TOSHITANI A, ANSEL JC, CHAN SC, Li SH, HANIFIN JM. Increased IL6 production by T cells derived from patients with atopic dermatitis. J Invest Dermatol 1993: 100: 299-304.
6. OHMEN JD, HANIFIN JM, NICKOLOFF BJ, et al. Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed-type hypersensitivity reactions. J Immunol 1995: 154: 1956-63.
7. Li SH, CHAN SC, KRAMER SM, HANIFIN JM. Modulation of leukocyte cyclic AMP phosphodiesterase activity by recombinant Interferon-gamma: Evidence for a differential effect on atopic monocytes. Interferon Res 1993: 13: 197-202.
8. COOPER KD. Atopic dermatitis: Recent trends in pathogenesis and therapy. J Invest Dermatol 1994: 151: 3345-52.
9. CHAN SC, Li SH, HANIFIN JM. Increased interleukin 4 production by atopic mononuclear leukocyte correlates with increased cyclic AMP-PDE activity and is reversible by PDE inhibition. J Invest Dermatol 1993: 100: 681-4.
10. CHAN SC, REIFSNYDER D. BEAVO JA. HANIFIN JM. Immunochemical characterization of the distinct monocyte cyclic AMP-phosphodiesterase from patients with atopic dermatitis. J Allergy Clin Immunol 1993: 91: 1179-88.
11. BARBERI I, SALPIETRO DC, DI BELLA MR, FULIA F. Considerazioni su alcuni aspetti patogenetici, clinici, terapeutici e preventivi dell'intolleranza alle proteine del latte vaccino (IPLV). Riv Pediatr Prev Soc 1995: 95: 85-91.
12. SALPIETRO DC, NACCARI F, BAGNATO GF, BARBERI I. Correlazione tra c-AMP ed IgE in neonati a rischio atopico. Atti 48 Congr Naz Pediatr Genova 1991: 118.
13. HANIFIN JM, RAJKA G. Diagnostic features of atopic dermatits. Acta Dermatol Venereol 1980: 92 Suppl: 44-47.
14. SAMPSON HA. Pathogenesis of eczema. Clin Exp Allergy 1990: 20: 459-67.
15. STEVENS SR, COOPER KD. Allergic skin diseases. Clinical Immunology: principles and practice. 1996: 952-65.
16. LI SH, CHAN SC, TOSHITANI A, LEUNG DYM, HANIFIN JM. Synergistic effects of interleukin 4 and interferon-gamma on monocyte phosphodiesterase activity. J Invest Dermatol 1992: 99: 65-70.
17. GREWE S, CHAN SC, HANIFIN JM. Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: a possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 1982: 70: 452-7.
18. BUTLER JM, CHAN SC, STEVENS SR, HANIFIN JM. Increased leukocyte histamine release with elevated cyclic AMP-phosphodiesterase activity in atopic dermatitis. J Allergy Clin Immunol 1983: 71: 490-7.